开利全球(Carrier)

最新新闻

• FDA Aprova Epcoritamabe, Da AbbVie, Como Primeiro E Único Anticorpo Biespecífico Para Tratamento De Adultos Com Linfoma Difuso De Grandes Células B Recidivados/Refratários (R/R)
  PR Newswire · 2023/5/29
• Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for Obecabtagene Autoleucel (Obe-cel) for Patients With Relapsed/refractory (R/r) Adult B-Cell Acute Lymphoblastic Leukemia (ALL)
  GlobeNewswire · 2023/11/27
• Richtech Robotics (RR): Reassessing an 8x Book Valuation After U.S. Robotics Policy Tailwinds and AI Partnerships
  Yahoo Finance · 2025/12/5
• BeOne Medicines' BEQALZI (Sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
  Yahoo Finance · 2026/5/14
• 公司公告
  CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - U.S. FDA GRANTED BREAKTHROUGH THERAPY DESIGNATION TO ANTI-PD-L1 ANTIBODY SUGEMALIMAB FOR THE TREATMENT OF ADULT PATIENTS WITH R/R ENKTL
  HKEX · 2020/10/23
• U.S. Stock Market Movement | Robotics Concept Stocks Strengthen as Richtech Robotics (RR.US) Surges Over 15%
  Zhitong Finance · 2025/10/3

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。